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Abstract
Leukemia, a blood cancer originating in the bone marrow, presents as a heterogeneous
disease with highly variable survival rates. Leukemia is classified into major types
based on the rate of cancerous cell growth and cell lineage: chronic or acute and myeloid
or lymphoid leukemia. Histological and cytological analysis of the peripheral blood and
the bone marrow can classify these major leukemia categories. However, histological
analyses of patient biopsies and cytological microscopic assessment of blood and bone
marrow smears are insufficient to diagnose leukemia subtypes and to direct therapy.
Hence, more expensive and time-consuming diagnostic tools routinely complement
histological-cytological analysis during a patient’s diagnosis. To extract more accurate
and detailed information from patient tissue samples, digital pathology is emerging as a
powerful tool to enhance biopsy- and smear-based decisions. Furthermore, digital
pathology methods integrated with advances in machine learning enable new diagnos-
tic features from leukemia patients’ histological and cytological slides and optimize
patient classification, thus providing a cheaper, more robust, and faster diagnostic tool
than current standards. This review summarizes emerging approaches to automatically
diagnose leukemia from morphological and cytological-histological analyses.
Keywords: blood cancer, acute leukemia, machine learning, digital pathology,
classification, supervised learning
1. Introduction
Leukemia is a very heterogeneous cancer that arises from the combination of many genetic and
epigenetic mutation events, all of which alter hematopoiesis [1–3]. Hematopoiesis is the
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proliferation of blood cells in the bone marrow (BM). Blood cells differentiate in the BM and,
then, when mature, spread out to the peripheral blood (PB) system. In normal circumstances,
the multipotent progenitor hematopoietic stem cells in the bone marrow reproduce and com-
mit to differentiate into common myeloid or lymphoid progenitor cells. Myeloid and lym-
phoid progenitor cells differentiate into two main cell lineages containing unipotential
precursor cells. Each precursor matures through multiple stages to become a red blood cell
(RBC), a platelet, or a white blood cell (WBC) type. Myeloid cells consist of RBCs, platelets,
segmented neutrophils, monocytes, eosinophils, basophils, and mast cells; lymphoid cells are
T and B lymphocytes, dendritic cells, or natural killer (NK) cells (Figure 1) [1, 4].
Malignant proliferation in the myeloid or lymphoid cell linage causes myeloid or lymphoid
leukemia. The diseased cells stop maturing, halt differentiation, and then accumulate, hence
blocking the development of healthy progenitor cells. Cell maturation in chronic leukemia is
blocked at a later stage, and it has a longer course of development compared to acute leuke-
mia, where lineage proliferation is arrested at an early stage of differentiation leading to a very
aggressive, fast-growing disease [4, 5].
Based on these two major differences, myeloid or lymphoid and chronic or acute, four major
leukemia types are distinguished: acute myeloid leukemia (AML), acute lymphoid leukemia
(ALL), chronic myeloid leukemia (CML), and chronic lymphoid leukemia (CLL). Each type has
a distinguishable morphology, and diagnosis is based on histological analysis of each patient’s
bone marrow biopsy and cytological microscopic assessment of bone marrow smear or periph-
eral blood smear [5, 6].
However, full classification requires more refined categories than the four major leukemia types,
and modern classification also includes mutation analysis, cytogenetics, and flow cytometry
data. Therefore, older morphological-based classification systems (French-American-British
(FAB)) cannot be fully matched with the World Health Organization (WHO) scheme, which
utilizes all of these features. The FAB classification system is predominantly used for the 30–
40% of AML cases that are not otherwise specified, while in special cases, a morphological
Figure 1. Schematic chart of hematopoiesis.
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pattern can be matched to an individual gene mutation or clinical criteria (e.g., AML t(8;21)(q22;
q22.1)/RUNX1-RUNX1T1 or AML with myelodysplasia-related changes) [7]. To enable more
personalized therapy, diagnosis and therapy selection require the analysis of histology and
cytology in combination with all clinical and genetic data of the patient including cytogenetics,
gene mutation analysis, and gene expression data obtained from flow cytometry [5, 6, 8, 9].
The ancillary diagnostic tests are costly and time-consuming, currently often requiring a week
or more, compared to the histological-cytological analysis, which can typically be performed
in a day. The delay in diagnosis can lead to delays in treatment, seriously impacting patients
suffering from acute leukemia. A faster, less time-consuming, and more precise automated
histology- and cytology-based diagnostic tool would facilitate diagnosis and personalized,
rapid treatment [10].
Due to the development of whole slide imaging (WSI), which yields large digital images
of an entire tissue sample, patients’ histological-cytological data are stored in an image
bank format to allow easy access to study their pathology. A digital tissue bank fosters
the computational, automated analysis of the histological-cytological images [11–14]. This
review describes possible solutions to integrate morphometrics obtained from images of
biopsy and smear samples with standard clinical covariates to optimize diagnosis and
direct therapy for leukemia.
2. Morphological diagnosis in leukemia
The current major standard diagnostic test in leukemia is histological-cytological analysis. This
includes basic light microscopy of routinely stained bone marrow biopsy, bone marrow smear,
and peripheral blood smear.
Diagnosis from the smear is established based on the complete blood count and differential
count (the proportion of specific cell types in the specimen). A biopsy can confirm the percent-
age of the specific cell types in the smear. Normal PB smear contains mature cells and up to
1–2% immature cells. The presence of immature cells at a significantly higher percentage leads
to the diagnosis of leukemia. Leukemia in the BM smear is detected based on the irregular
proportion of specific immature cells and their morphological alterations [1].
Based on abnormally high proportions of specific blood cells and morphological dysplasia in
the biopsy and smear specimen, the French-American-British (FAB) system describes a
morphologically based classification for acute leukemia. AML subtypes are divided into
eight different groups (M0–M7) and ALL subtypes into three different groups (L1–L3). Such
classification system for chronic leukemia is less precise, where the subtypes are overlapping
[5, 9].
Although the FAB classification system is based on cellular appearance, some immature cells
do not have distinguishable morphological characteristics. Immunophenotyping confirms the
diagnosis, especially in ALL T- and B-cell lineage and AML minimally differentiated (M0) and
AML megakaryoblastic (M7) subtypes [5].
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As a result, histology and cytology are major diagnostic tools: however, their current prognos-
tic potential is limited, as the majority of genetic events do not have known, defining morpho-
logical characteristics [5, 10]. Thanks to emerging computer technologies, a pathologist’s
qualitative decision can be supported by an automated quantitative decision tool. Morphomet-
rics of the pathological slides can both provide new diagnostic information not visible to the
naked eye and improve the prognostic ability of histological-cytological analyses [15, 16].
3. Digital cytology analysis
Statistical analysis of cells and cellular features can guide a pathologist’s diagnosis of leuke-
mia. The number of RBCs, WBCs, and platelets, the proportion of specific immature and
mature cells, and more detailed morphological features recognized by automated WSI can all
help direct a diagnosis. Digital image analysis of BM biopsy has been applied to study relapse
in AML [17, 18]. The focus of most prior studies has been recognition of the acute leukemia
FAB subtypes or differentiation of acute and chronic leukemia from the PB and BM smears.
While PB and BM smears can differ in the type and maturation of their cells, the quantitative
process to recognize the cell types and extract morphometric information is similar. We
describe it below:
Following steps a pathologist would take, computer-based digital pathology aims to detect,
localize, and recognize the specific cell type under study (Figure 2). An acquired image is
preprocessed through image enhancement steps; then, cells are detected, and cell boundaries
are traced out using segmentation algorithms for morphometric analysis.
Processing steps to automate the analysis of leukemia smear images are shown in Figure 2. A
whole slide image (WSI) of a Wright-Giemsa-stained bone marrow smear is shown in
Figure 2a. This is a typical smear image annotated by a pathologist. The Wright-Giemsa-
stained image reveals RBCs as smaller pink cells without nuclei (either distributed as single
cells or clustered) and a few WBCs of different sizes with dark purple nuclei. Notably, image
acquisition techniques, staining methods, and digitization protocols can differ in each labora-
tory. Furthermore, environmental effects can introduce artifacts and degrade the quality of the
image. Image preprocessing steps can improve the image quality and correct for differences in
protocols and in illumination. Methods of image correction techniques include illumination
Figure 2. Image processing pipeline (a–e: Image from Carlos Bueso-Ramos, MD, PhD, MD Anderson Cancer Center).
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normalization, color or stain correction for image enhancement, contrast enhancement and
smoothing, contrast stretching, and histogram equalization [19–21].
Leukemia is detected based on the number, type, and proportion of various cell types in the
blood. Segmentation algorithms enable identification of individual cells from smear images
(Figure 2b); these algorithms can distinguish overlapping cells from individual cells in order to
extract cell-based features and can also divide each WBC into its components: cell membrane,
nucleus, and cytoplasm (Figure 2c) [19, 21–37]. Following segmentation, metrics can be
extracted from the WBCs and their subcellular components (cell size, nuclear size, etc.).
4. Quantification of cytology using machine learning
To computationally classify tissue types from smear images, identified cells and tissues in the
images have to be transformed into a vector of features. Conventional machine learning
algorithms typically utilize a domain-specific approach to classify cell and tissue types based
on a series of handcrafted features. These algorithms extract metrics from images based on a
human engineering process that requires domain knowledge [38, 39].
Features of the smear sample can be extracted from an individual cell in the image or across
the entire slide. Once a WBC is segmented within the image, features are extracted either from
the whole WBC or separately from the nucleus and cytoplasm. The major discriminating
cellular characteristics to classify WBCs are (a) geometric features such as shape (e.g., round-
ness) and size (e.g., nucleus-cytoplasm size ratio); (b) color features; (c) texture features such as
density, granularity, and Fourier descriptors for texture quantification calculated by the two-
dimensional Fourier transform; and (d) irregularity or boundary roughness measured by
fractal dimension [10, 23, 33, 35, 40–49]. Although the analysis at the single cell level provides
useful information, it is not sufficient for the diagnosis of a very heterogeneous disorder such
as leukemia. In addition to single cell data, characteristics of multicellular groups need to be
studied [1]. New studies have extended cell-based morphometric analysis to distinguish major
leukemia types and subtypes (Table 1).
The common characteristics in these studies are general steps of the image processing pipeline:
preprocessing, segmentation, feature engineering, and supervised classification (Table 1).
They discriminate cancerous vs. healthy tissue, AML vs. ALL, CL vs. AL, or AML and ALL
subtypes. The main differences across the various studies are the choice of the specific engineered
features and the choice of the classification method as illustrated below.
Most of the digital pathology studies of leukemia analyze PB. A healthy blood smear is
distinguished from a leukemic smear if one or more immature cells are present. This can be
determined from the nucleus structure or from whole cell characteristics. Discriminating
features that classify healthy tissue, AML and ALL in the PB are extracted from the cell
nucleus. BM is more heterogeneous than PB, and features of BM images are extracted from
the whole cells or separately from the nuclei and the cytoplasm. Commonly used features
include texture-based metrics and morphology. Texture is based on the spatial variation of the
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gray-level pixel intensities which can be characterized by their homogeneity, energy, and
correlation, among other metrics represented in the gray-level co-occurrence matrix (GLCM).
Shape is based on geometrical parameters such as area, perimeter, compactness, minor axis,
Reference Leukemia type Extracted features Classification
Reta et al. 2015 [58] BM (Bone marrow): AML vs
ALL, M2 vs M3 vs M5 vs vs L1
vs L2
Cell + nucleus + cytoplasm:
Shape: area, perimeter,
circularity, width, Length,
elongation, major axis, minor
axis, eccentricity, extent,
equivalent diameter, Euler
number, Convex area Size
Ratio: Nucleus/Cytoplasm area,
Nucleus/Cell area and
perimeter Color/Pixel Intensity
Statistics: Mode, Mean,
Standard deviation, Variance,
Sum Texture: Homogeneity,
Contrast, Correlation, Energy,
Entropy 10 Eigenvalues (PCA)
of R, G, B channel of RGB image
and of gray image
k-nearest neighbor (kNN),
Random Forest (RF), Simple
Logistic (SL), Support Vector
Machines (SMV), Random
Committee (RC)
Kazemi et al. 2016
[57]
PB (Peripheral blood): AML vs
Healthy, M2 vs M3 vs M4 vs vs
M5 vs (M1+M6+M7)
Nucleus: Shape: Area,
Permieter, Elongation, Major
and Minor axis, Solidity,
Eccentricity, Form Factor,
Compactness, Size Ratio:
Nuclues/Cytoplasm Color:
Mean, Standard deviation,
Variance Texture: Energy,
Entropy, Contrast, Correlation,
Homogeneity Fractal:
Hausdorff dimension (HD)
Nucleus boundary Irregularity
Support vector machine (SVM)
Madhukar et al.
2012 [54]
PB: AML vs Healthy Nucleus:
Texture: Gray-Level
Co-occurrence Matrix:
Contrast, Homogeneity, Energy,
Entropy, Correlation
Image Slide:
Fractal: HD dimension
Support vector machine (SVM)
Agaian et al. 2014
[53]
PB: AML vs Healthy Nucleus:
Shape: Area, Parameter,
Compactness, Minor and Major
Axis, Eccentricity, FormFactor,
Elongation, Solidity Color:
Standard deviation, Mean,
Energy Texture: GLCM:
Homogeneity, Contrast,
Correlation Fractal: HD
dimension
Image Slide:
Fractal: HD dimension
Support Vector Machine (SVM)
Hematology - Latest Research and Clinical Advances100
Reference Leukemia type Extracted features Classification
Vaghela et al. 2016
[62]
PB: CLL vs CML Nucleus: Roundness + Count Not applied
Jacob et al. 2016
[50]
PB: AML vs ALL vs Healthy Nucleus:
Shape: Area, Parameter,
Compactness, Minor and Major
Axis, Eccentricity, FormFactor,
Elongation, Solidity Texture:
GLCM: Homogeneity, Energy,
Contrast, Correlation Fractal:
HD dimension
Support Vector Machine (SVM)
Supardi et al. 2012
[55]
PB: ALL vs AML Cell:
Shape: Size: Area, Radius,
Perimeter Second order central
moment Color: std and mean
variance of Red, Green, Blue
and intensities of RGB color
k-Nearest-Neighbor (kNN)
Gumble et al. 2017
[51]
PB: ALL vs Healthy Nucleus & cytoplasm (Binary
gray):
Shape/Texture: Area, Total
White Cells, Total Black Pixels,
Perimeter, Eccentricity, Solidity,
Form Factor, Bounding Box
k-Nearest-Neighbor (kNN)
Harun et al. 2011
[56]
PB: AML vs ALL Cell & cytoplasm & nucleus:
Shape: Area, Nucleus/
Cytoplasm Size Ratio
Cell & Nucleus:
Shape: Perimeter
Hybrid Multilayer Perceptron
Neural Network (HMLP NN)
Escalante et al.
2012 [59]
BM: ALL vs AML, L1 vs L2, M2
vs (M3+M5), M3 vs (M2+M5),
M5 vs (M2+M3), M1 vs M3 vs
M5, L1 vs L2 vs M1 vs vs M3 vs
M6
Cell & nucleus: Shape: Area,
Perimeter, Circularity, Width,
Height, Elongation, Major and
Minor Axis, Eccentricity,
Extension, Diameter, Euler
number, Convex number,
Solidity Pixel intensity
Statistics: Mode, Mean,
Standard deviation, Variance,
IOD, avg. IOD Texture:
Entropy, Contrast, Correlation,
Energy, Homogeneity
Eigenvalues (PCA) - R,G,B,
grayscale
Cytoplasm:
Shape: Area Pixel Intensity
Statistics: Mode, Mean,
Standard deviation, Variance
Eigenvalues (PCA) - R,G,B,
grayscale
Ensemble Particle Swarm
Model Selection (ESPMS)
Mohapatra et al.
2014 [52]
PB: ALL vs Healthy Nucleus & cytoplasm& cell:
Shape: Area
Nucleus & Cytoplasm:
Color: mean intensity of R,G,B
and Hue, Saturation, Lightness
components Texture: Wavelet
Ensemble of Classifiers (EOC),
Naive Bayesian (NB), K-nearest
neighbor (KNN), Multilayer
Perceptron (MLP NN), Radial
Basis Functional Network
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Reference Leukemia type Extracted features Classification
coefficients and GLCM
statistics: Contrast, Correlation,
Energy, Homogeneity, Entropy
Nucleus:
Shape: Form Factor,
Roundness, Compactness,
Elongation, Perimeter Color:
mean intensity of R,G,B and
Hue, Saturation, Lightness
components Texture: Fourier
transform: Mean, variance,
skewness, kurtosis of the
frequency components
Boundary roughness: Fractal
HD dimension Contour
signature: Variance, skewness,
kurtosis (center-contour)
(RBFN), Support Vector
Machine (SVM)
Mohapatra thesis
2013 [61]
PB:L1 vs L2 vs L3 Nucleus & Cytoplasm & Cell:
Shape: Area
Nucleus & Cell:
Shape: Size ratio: Nucleus / Cell
Nucleus & Cytoplasm:
Color: RGB and HSV
components
Cytoplasm:
Vacuole count
Nucleus:
Shape: Form Factor,
Roundness, Compactness,
Elongation, Perimeter Nucleus
Indentation, Nucleoli count,
Texture: Frourier descriptor,
Wavelet and Haralick
coefficients (GLCM statistics):
Contrast, Correlation, Energy,
Homogeneity, Entropy
Ensemble of classifiers (EOC),
Naive Bayesian (NB),
K-nearest neighbor (KNN),
Multilayer Perceptron
(MLP NN),
Radial Basis Functional
Network (RBFN),
Support Vector Machine (SVM)
Mohapatra thesis
2013 [61]
PB: ALL vs AML Nucleus & cytoplasm & cell
Shape: Size
Cytoplasm:
Color: RGB and HSV
components Texture:
Coarseness Intensity and shape:
Auer Rodes as Cytoplasmic
Holes
Nucleus:
Nucleoli count Texture:
Frourier descriptor, Wavelet
and Haralick coefficients
(GLCM statistics): Contrast,
Correlation, Energy,
Homogeneity, Entropy
Ensemble of Classifiers (EOC),
Naive Bayesian (NB), K-nearest
neighbor (KNN), Multilayer
Perceptron (MLP NN), Radial
Basis Functional Network
(RBFN), Support Vector
Machine (SVM)
Table 1. Leukemia subtype classification.
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major axis, eccentricity, form factor, elongation, and solidity. Fractal or Hausdorff dimension
(HD) represents the nucleus boundary roughness (Jacob and Mundackal) [50].
4.1. Examples of digital pathology for leukemia
To provide examples of digital pathology’s impact in leukemia classification, we summarize
here a few of the recent studies. In one study, ALL cells were distinguished from healthy PB cells
from shape and texture features extracted from the nucleus and cytoplasm (Gumble and Rode).
These features included area, total white blood cells, total black pixels, perimeter, eccentricity,
solidity, form factor, and bounding box parameters [51]. In another study, Mohapatra et al.
added color and the Fourier descriptor as a cell-based nuclear feature to the shape, fractal, and
texture parameters to distinguish ALL from healthy lymphoblasts/lymphocytes [52].
What literally do these features mean? In the Mohapatra et al. study, color features of a cell
were calculated from the mean intensity of the nucleus color components in RGB or HSV color
space and from a grayscale intensity map. In the case of RGB images, the mean intensity of the
red, green, and blue channels and, in the case of HSV images, the mean intensity of the hue,
saturation, and lightness components were computed. The same color features were calculated
for the cytoplasm. The Fourier descriptors were the mean, variance, skewness, and kurtosis of
the texture in the frequency domain. The fractal/HD of the nucleus boundary roughness was
considered, as was the variance, skewness, and kurtosis computed between the cell’s center
and each contour point. Texture features from the cytoplasm included wavelet coefficients and
metrics derived from the GLCM including contrast, correlation, energy, homogeneity, and
entropy values. The area was calculated for the nucleus, cytoplasm, and the whole cell [52].
In addition to determining leukemia from cell-based features, AML can be distinguished from
healthy tissue by extracting whole tissue/slide-based features as illustrated in two other
studies (Madhukar et al., Agaian et al.) [53, 54].
Furthermore, AML can also be distinguished from ALL through comparing cellular features in
patient smears, as shown by Jacob and Mundackal [50], Supardi et al. [55], and Harun et al.
[56]. Jacob et al. and Supardi et al. used cellular metrics based on texture, shape, and Hausdorff
dimension, while Harun et al. classified the two leukemias by cell and nuclear perimeters,
areas of the cytoplasm and whole cells, and nucleus-cytoplasm ratio [56].
More specifically, AML and ALL subtypes have been discriminated based on cell-based fea-
tures in three different studies. To classify AML subtypes, Kazemi et al. predicted five AML
groups (M2, M3, M4, M5, and all the remaining subtypes (M0, M1, M6, M7) considered as one
group) based on handcrafted morphological features from blood microscopic images. The
features used were extracted from cells’ nuclei: irregularity, Hausdorff dimension, shape, color,
and texture features complemented by the nucleus-cytoplasm ratio. The same set of features
allowed more accurate discrimination of healthy tissue vs. AML tissue than AML tissue vs.
ALL tissue [57]. Reta et al. performed a similar analysis which discriminated L1, L2, M3, M3,
and M5 subtypes in ALL and AML based on cellular features, with nucleus features proving to
be the most discriminative [58]. An earlier study (Escalante et al.) was also able to discriminate
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multiple leukemia tissue types from the BM: ALL vs. AML, L1 vs. L2, M2 vs. M3 + M5, M3 vs.
M2 + M5, M5 vs. M2 + M3, M1 vs. M3 vs. M5, and L1 vs. L2 vs. M1 vs. M3 vs. M5 [59].
However, in the latter study, there was no significant difference in model performance using
features extracted from the nucleus and cytoplasm vs. the whole cell.
This contradicts other studies that suggest classification based on subcellular morphometry
improves AML [60] and ALL [61] subtype recognition. In particular, these groups found that
color and shape information in the cytoplasmic holes, which indicate vacuoles, and color and
shape information on the nucleus, which indicate nucleoli, can reveal the presence of Auer
rods discriminating AML from ALL where Auer rods are absent [61].
In addition to the large number of publications characterizing acute forms of leukemia, studies
(Vaghela et al.) have suggested measurements of WBC roundness and counts can discriminate
chronic myeloid vs. chronic lymphoid leukemia [62].
4.2. Classification methods
4.2.1. Traditional machine learning methods
Support vector machine (SVM) is a common classification method in leukemia (Jacob et al.
[50]; Agaian et al. [53]; Kazemi et al. [57]; Madhukar et al. [54]). However, other methods
(Supardi et al., Gumble and Rode) have been applied with success to classify AML and ALL
histology and cytology images including k-nearest neighbor classifiers [51, 55], a hybrid
multilayer neural network (HMLNN) (Harun et al.) [56], and an ensemble particle swarm
model selection method (EPSMS) (Escalante et al.) [59]. Alternatively, Kumar et al. suggested
using a shallow neural network (NN) classifier after the AML slide is processed using wavelet
transformation [37]. Other groups (Mohapatra et al.; Reta et al.; Escalante et al.) have com-
pared multiple classifiers on leukemia image datasets and found that depending on the target,
different classification methods appear to be the optimal solution [52, 58, 59].
When a small amount of data is available, conventional feature engineering-based machine
learning algorithms provide fairly accurate predictions [39]. The accuracy of feature engineering
proposed models depends on the distinct leukemia databases studied, the number and quality
of the images, and the image acquisition mode; these require different data preprocessing steps.
These methods are mainly based on supervised classification of leukemia subtypes. When the
set of quantitative morphological features of the leukemia subtype is trained on a labeled
dataset, then classifiers have been able to predict the four major leukemia types or the FAB
classes applied to a test set. In case of insufficient number of training samples, Kasmin et al.
proposed reinforcement learning to classify ALL, AML, CLL, and CML from PB cellular
nucleus’ geometrical, texture, color, and statistical parameters [63].
Although these previous studies found new morphological features from the digitalized leu-
kemia patient histology slides, and were successfully able to identify the major leukemia types
and M0–M7 and L1–L3 subtypes, morphological features from the leukemia cells were not
correlated with non-morphological information such as genetic mutations and clinical data.
The morphological classification methods currently are not sufficient to recognize the majority
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of the underlying molecular abnormalities and cannot be used to direct therapy. In addition,
the subtype groups’ underlying genetic patterns are not unique per subtype. Should morpho-
logical classification match genetic backgrounds, this could help speed up the diagnosis pro-
cess. One study attempted to correlate morphological quantitative features in order to classify
ALL lymphoblasts into the WHO subtypes and compare the results with flow cytometry
analysis. To this aim, an unsupervised feature selection method was applied, and an optimal
subset of the features was extracted to match the WHO classification [61]. This study and
others that follow are helping pave the way for increasingly sophisticated means of classifying
leukemia by images that enable incorporation of genetic and epigenetic details. Advances in
computational methods are too, as the next section describes.
4.2.2. Deep learning methods
Although engineered feature-based conventional machine learning algorithms provide fairly
accurate predictions, they do not reach the capability of human perception. The feature engi-
neering process requires defining a carefully chosen set of features. This is a laborious process,
and the feature parameters are very sensitive to the specific training set from where they were
extracted. Due to this rigidity, a conventional machine learning algorithm likely could not be
applied to a second dataset without parameter tweaking. To overcome these limitations, deep
learning algorithms trained on large amounts of data can extract generalized features to
perform human-level pattern recognition [64, 65].
When a large amount of data is available, for identifying morphological features in leukemia, a
deep learning approach can be applied. Deep learning can self-discover new, hierarchical fea-
tures in images (feature learning) allowing better pattern recognition for classification. These
features are identified without human knowledge, and the learning approach is called “domain-
agonistic,” where the computational system alone is able to distinguish distinct tissue types in
any type of cancer. Today, with the increasing computing capacity of modern computers and the
availability of big data storage, huge amounts of data can now be extracted and analyzed to
identify key features for classification. This has enabled deep learning methods to outperform
previous conventional machine learning approaches and to achieve higher accuracy [39, 66].
Deep learning is the extension of conventional, artificial neural networks where, instead of a
single-layered network, a multilayered connected network processes input data and generates
output. The network design is dependent on the input dataset and classification target. For
pattern classification problems, convolutional neural networks (CNNs) are the ideally suited
network design. The network learns from the example images fed to it and extracts hierarchi-
cal features automatically layer by layer (e.g., from low-level features like edges to higher-level
features such as the cell, tissue, and then organ) without expert human intervention while
retaining highly expressive power (Figure 3) [65–67].
The input of the CNN is a series of images, cropped from the whole slide image, and the images
are processed in batch. For WBC classification, one cropped image contains one whole cell.
Contrary to the cell-based analysis, for tissue classification, the images are slide-based, so the
features are learned directly from the spatial pattern. The image size and the number of images
fed to the network should be chosen carefully, and the variety of images should represent the
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variability of the tissue type. Grayscale images are two-dimensional: width and height. Color
images have a third dimension, depth, representing the RGB color channels [38, 65, 67, 68].
Once the set of images is defined and labeled, feature maps are created by sliding a series of
filters representing shapes, textures, or colors over the input image (convolution), thus identify-
ing local dependencies. The filters representing the features are learned during the training
process through backpropagation and a gradient descent algorithm. After convolution, an acti-
vation process introduces nonlinear properties to the linear convolution to improve the model
accuracy and to avoid overfitting. The convolutional layer then is down-sampled (pooling). This
is successively repeated as many times as necessary according to the hierarchical complexity of
the image. The last feature map is then flattened into a one-dimensional vector to feed a fully
connected layer for neural network (NN) classification. The NN classification process can be
replaced by a different classification scheme such as an SVM or random forest [38, 65, 67, 68].
Convolutional neural networks are ideally suited for pattern recognition and medical image
analysis. In fact, CNNs have been successfully applied to feature learning to detect and
diagnose a number of different cancers, including leukemia cells. Deep learning methods have
been used for white blood cell detection and classification [68], lymphocyte detection [38], and
lymphoma subtype classification [38] by identifying three subtypes of lymphoma: chronic
lymphocytic leukemia (CLL), follicular lymphoma (FL), and mantle cell lymphoma (MCL). It
also has been applied to the analysis of ALL cellular images to classify ALL subtype histopa-
thology [67, 69].
Although the current research in pattern recognition is dominated by the supervised deep
learning approach, the unsupervised approach is expected to provide breakthrough results in
the near future, and extensive research is currently ongoing to optimize these algorithms [65, 66].
5. Conclusions and future outlook
Standard leukemia diagnosis and therapy are currently based on morphological classification
of patients’ bone marrow smears and biopsies, peripheral blood smears, and molecular and
cytogenetic analyses to identify genetic abnormalities. However, morphological and genetic
classification analysis is insufficient to fully predict appropriate response to therapy, while
Figure 3. Feature learning for classification.
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emerging nonstandard methods to improve and personalize leukemia classification can be
expensive and time-consuming. Digital pathology is emerging as a powerful, inexpensive tool
to enhance biopsy- and smear-based decisions.
This review discussed how computational cytology can help improve leukemia diagnosis by
enhancing pathologist smear-based decisions and improve leukemia diagnosis with auto-
mated, biologically meaningful pattern recognition. Techniques summarized in this review
extract quantitative imaging features from stained bone marrow and peripheral blood smear
samples to detect and classify leukemia. To identify morphological features, conventional
machine learning approaches have been broadly applied to classify leukemia types and sub-
types based on feature engineering. However, to acquire a new set of morphological features
in leukemia, a deep learning approach would provide higher accuracy.
For most of the cases reviewed in this chapter, the image processing pipeline implements a
supervised classification scheme, where the morphometric features are extracted from a set of
labeled data (ALL vs. AML, FAB, M1, etc.) and then are validated on a test dataset. In future
studies, supervised morphological analysis can be complemented with unsupervised classifi-
cation schemes such as unbiased clustering. This approach could reveal whether entirely new
classification schemes should be implemented for ALL or AML, independent from known
acute or chronic leukemia subtype morphological classification. It also could potentially reveal
common underlying genetic or proteomic patterns.
Emerging omics analysis methods are determining protein expression signatures for leukemia
patients; however, these new processes can be time and labor intensive. To determine genetic
information and protein signature membership rapidly and without the time delay required
for proteomic-based signature assignment, advances in digital pathology offer potentially
exciting, inexpensive, rapid alternatives. If morphological surrogates that reliably correlate
with clinical, genetic, or proteomic features, either individually or in combinatorial patterns,
can be identified directly from histology images, then this could significantly speed up leuke-
mia diagnosis, reduce the cost of the diagnostic workup, optimize the assignment of patients to
a particular therapy, and potentially uncover new pathways for drug targeting.
Cell metrics can be predefined manually, and often metrics are those known to be pertinent
to leukemia cells. These algorithms, which together are employed as part of a “feature
engineering process,” extract metrics from images based on features of cells (e.g., size or
nucleus shape). Using a supervised classification approach, the metrics are extracted from
predefined leukemia subtypes. As an example, a set of quantitative morphological features
defining a leukemia subtype are trained on a labeled dataset according to the FAB morpho-
logical classes, and the resulting developed classifier is then used to predict the leukemia
subtypes on a test set.
In the unsupervised classification approach, new clusters of leukemia subtypes are created
from the engineered features. Contrary to the feature engineering process, learning algorithms
self-discover features representative of leukemia cell types (feature learning) where features
are learned from annotated (supervised) or unannotated (unsupervised) data (Figure 2).
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